Clinical Trial Update: OptiScanner Versus Standard Blood Glucose Monitoring

View source ↗

Summary

This document reports the completion of a clinical trial comparing OptiScanner to standard blood glucose monitoring in patients with hyperglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia

Drugs mentioned

• OptiScanner

Snippet

Sponsor: OptiScan Biomedical Corporation | Conditions: Hyperglycemia | Status: COMPLETED